Sartorius Aktiengesellschaft (SRT3.DE)
EUR 209.0
(-2.34%)
EUR 209.0
(-2.34%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 920.1 Million EUR | -40.75% |
| 2022 | 1.53 Billion EUR | 47.16% |
| 2021 | 945.12 Million EUR | 37.34% |
| 2020 | 662.12 Million EUR | 44.12% |
| 2019 | 463.53 Million EUR | 20.59% |
| 2018 | 409.17 Million EUR | 15.99% |
| 2017 | 326.22 Million EUR | 8.71% |
| 2016 | 297.2 Million EUR | 26.43% |
| 2015 | 252.59 Million EUR | 36.77% |
| 2014 | 169.56 Million EUR | 8.36% |
| 2013 | 155.12 Million EUR | 4.72% |
| 2012 | 146.25 Million EUR | 29.2% |
| 2011 | 123.88 Million EUR | 17.13% |
| 2010 | 108.21 Million EUR | 87.26% |
| 2009 | 54.31 Million EUR | -28.69% |
| 2008 | 81.04 Million EUR | 3.49% |
| 2007 | 78.3 Million EUR | 8.63% |
| 2006 | 72.08 Million EUR | 33.1% |
| 2005 | 56.38 Million EUR | 7.67% |
| 2004 | 50.3 Million EUR | 53.37% |
| 2003 | 32.79 Million EUR | 6.82% |
| 2002 | 30.7 Million EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 239.5 Million EUR | -6.19% |
| 2024 Q2 | 247.8 Million EUR | -5.5% |
| 2024 Q3 | 181.2 Million EUR | -12.08% |
| 2023 Q2 | 285.2 Million EUR | 4.74% |
| 2023 Q4 | 155.5 Million EUR | -14.33% |
| 2023 Q1 | 272.3 Million EUR | -6.62% |
| 2023 Q3 | 181.5 Million EUR | -36.36% |
| 2023 FY | - EUR | -40.75% |
| 2022 Q3 | 387.6 Million EUR | -0.77% |
| 2022 Q4 | 291.6 Million EUR | -24.77% |
| 2022 FY | - EUR | 47.16% |
| 2022 Q1 | 434.1 Million EUR | 588.86% |
| 2022 Q2 | 390.6 Million EUR | -10.02% |
| 2021 FY | - EUR | 37.34% |
| 2021 Q4 | 63.01 Million EUR | -79.3% |
| 2021 Q1 | 268.8 Million EUR | 56.6% |
| 2021 Q2 | 290.3 Million EUR | 8.0% |
| 2021 Q3 | 304.5 Million EUR | 4.89% |
| 2020 Q3 | 196.9 Million EUR | 36.64% |
| 2020 Q1 | 138.2 Million EUR | 16.49% |
| 2020 Q4 | 171.64 Million EUR | -12.83% |
| 2020 FY | - EUR | 44.12% |
| 2020 Q2 | 144.1 Million EUR | 4.27% |
| 2019 Q2 | 120.2 Million EUR | 7.51% |
| 2019 FY | - EUR | 20.59% |
| 2019 Q4 | 118.63 Million EUR | -0.73% |
| 2019 Q1 | 111.8 Million EUR | 6.95% |
| 2019 Q3 | 119.5 Million EUR | -0.58% |
| 2018 Q2 | 94.1 Million EUR | 10.71% |
| 2018 Q1 | 85 Million EUR | 27.82% |
| 2018 Q3 | 102.7 Million EUR | 9.14% |
| 2018 FY | - EUR | 15.99% |
| 2018 Q4 | 104.53 Million EUR | 1.78% |
| 2017 Q4 | 66.5 Million EUR | -17.18% |
| 2017 Q3 | 80.3 Million EUR | -5.42% |
| 2017 Q2 | 84.9 Million EUR | 6.52% |
| 2017 Q1 | 79.7 Million EUR | 38.02% |
| 2017 FY | - EUR | 8.71% |
| 2016 Q2 | 81 Million EUR | 14.57% |
| 2016 Q4 | 57.74 Million EUR | -27.82% |
| 2016 Q3 | 80 Million EUR | -1.23% |
| 2016 Q1 | 70.7 Million EUR | 51.51% |
| 2016 FY | - EUR | 26.43% |
| 2015 Q1 | 60.3 Million EUR | 99.98% |
| 2015 Q4 | 46.66 Million EUR | -35.01% |
| 2015 Q3 | 71.8 Million EUR | 15.62% |
| 2015 Q2 | 62.1 Million EUR | 2.99% |
| 2015 FY | - EUR | 36.77% |
| 2014 FY | - EUR | 8.36% |
| 2014 Q3 | 48.6 Million EUR | 4.07% |
| 2014 Q1 | 39 Million EUR | 3.32% |
| 2014 Q2 | 46.7 Million EUR | 19.74% |
| 2014 Q4 | 30.15 Million EUR | -37.96% |
| 2013 Q3 | 39.9 Million EUR | -9.11% |
| 2013 Q4 | 37.74 Million EUR | -5.4% |
| 2013 Q2 | 43.9 Million EUR | 11.42% |
| 2013 Q1 | 39.4 Million EUR | 2.64% |
| 2013 FY | - EUR | 4.72% |
| 2012 Q2 | 36.4 Million EUR | 0.55% |
| 2012 Q1 | 36.2 Million EUR | 7.88% |
| 2012 FY | - EUR | 29.2% |
| 2012 Q4 | 38.38 Million EUR | -6.15% |
| 2012 Q3 | 40.9 Million EUR | 12.36% |
| 2011 Q1 | 29.4 Million EUR | 5.59% |
| 2011 Q3 | 34.6 Million EUR | 18.9% |
| 2011 Q4 | 33.55 Million EUR | -3.02% |
| 2011 Q2 | 29.1 Million EUR | -1.02% |
| 2011 FY | - EUR | 17.13% |
| 2010 FY | - EUR | 87.26% |
| 2010 Q2 | 25.2 Million EUR | 16.67% |
| 2010 Q4 | 27.84 Million EUR | 2.75% |
| 2010 Q1 | 21.6 Million EUR | 14.95% |
| 2010 Q3 | 27.1 Million EUR | 7.54% |
| 2009 Q1 | 16.1 Million EUR | 0.0% |
| 2009 Q4 | 18.79 Million EUR | -2.64% |
| 2009 Q3 | 19.3 Million EUR | 216.39% |
| 2009 Q2 | 6.1 Million EUR | -62.11% |
| 2009 FY | - EUR | -28.69% |
| 2008 FY | - EUR | 3.49% |
| 2007 FY | - EUR | 8.63% |
| 2006 FY | - EUR | 33.1% |
| 2005 FY | - EUR | 7.67% |
| 2004 FY | - EUR | 53.37% |
| 2003 FY | - EUR | 6.82% |
| 2002 FY | - EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| SCHOTT Pharma AG & Co. KGaA | 227.64 Million EUR | -304.184% |
| Carl Zeiss Meditec AG | 502.77 Million EUR | -83.006% |
| Fielmann Aktiengesellschaft | 403.8 Million EUR | -127.858% |
| Gerresheimer AG | 400.56 Million EUR | -129.701% |
| Sartorius Aktiengesellschaft | 920.1 Million EUR | 0.0% |